Archives

  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Ampicillin Sodium: β-Lactam Antibiotic Mechanism & Resear...

    2025-12-28

    Ampicillin Sodium: β-Lactam Antibiotic Mechanism & Research Utility

    Executive Summary: Ampicillin sodium (CAS 69-52-3) is a β-lactam antibiotic that inhibits bacterial transpeptidase enzymes, disrupting cell wall synthesis and leading to cell lysis (APExBIO product data). It demonstrates an IC50 of 1.8 μg/ml against E. coli 146 transpeptidase and a minimum inhibitory concentration (MIC) of 3.1 μg/ml under standard in vitro conditions (Burger et al., 1993). Ampicillin sodium is water-soluble (≥18.57 mg/mL) and widely used in antibacterial activity assays and bacterial infection models. High-purity preparations (≥98%) are available, supported by NMR and MS quality control. Its mechanism informs both resistance modeling and the optimization of recombinant protein workflows.

    Biological Rationale

    Ampicillin sodium is a semi-synthetic β-lactam antibiotic designed to target both Gram-positive and Gram-negative bacteria (see reference). Bacterial cell wall biosynthesis requires transpeptidase enzymes (penicillin-binding proteins, PBPs) for cross-linking peptidoglycan strands. Disruption of this process impairs structural integrity and leads to osmotic lysis. The compound's pharmacological relevance is underpinned by its stable inhibition profile, making it a model agent in studies of antibiotic resistance and cell wall-targeted therapies. Unlike older penicillins, ampicillin sodium can be used in a broad range of bacterial species, extending its utility in translational research and recombinant workflows (contrast: broader substrate profile).

    Mechanism of Action of Ampicillin sodium

    Ampicillin sodium acts as a competitive inhibitor of bacterial transpeptidases, enzymes critical to the final stages of peptidoglycan cross-linking (product page). The β-lactam ring mimics the D-Ala-D-Ala moiety of peptidoglycan precursors, allowing covalent binding to the active site serine of PBPs. This acylation event is irreversible under physiological conditions, rendering the enzyme inactive. The loss of transpeptidase activity prevents proper cell wall assembly, resulting in weakened cell membranes and subsequent lysis due to osmotic pressure (Burger et al., 1993). The process is dose-dependent and quantifiable via MIC and IC50 values under defined conditions.

    Evidence & Benchmarks

    • Ampicillin sodium has an IC50 of 1.8 μg/ml against transpeptidase in E. coli 146 cells under standard buffer conditions (Burger et al., 1993, DOI).
    • The minimum inhibitory concentration (MIC) against E. coli is 3.1 μg/ml, as determined by in vitro broth microdilution assays (source: APExBIO).
    • Ampicillin sodium is highly soluble in water (≥18.57 mg/mL), DMSO (≥73.6 mg/mL), and ethanol (≥75.2 mg/mL), facilitating high-concentration stock solutions (see product specs).
    • Purity levels of ≥98% are confirmed via NMR and MS, supporting reproducible results in sensitive biochemical and microbiological assays (COA data).
    • In recombinant protein workflows (e.g., annexin V expression), ampicillin sodium at 50 μg/ml is effective for bacterial selection without cross-reactivity with eukaryotic proteins (Burger et al., 1993, DOI).

    Applications, Limits & Misconceptions

    Ampicillin sodium is extensively used in:

    • Antibacterial activity assays against both Gram-positive and Gram-negative bacteria.
    • Selection of recombinant bacterial clones in molecular biology (e.g., protein expression systems).
    • Animal infection models for in vivo efficacy and resistance studies.
    • Functional evaluation of PBPs and antibiotic resistance mechanisms (further reading; this article provides updated mechanistic quantitation relevant to resistance modeling).

    Common Pitfalls or Misconceptions

    • Not effective against β-lactamase-producing strains: Ampicillin sodium is hydrolyzed by common β-lactamases; resistance is frequent unless enzymes are absent or inhibited.
    • Not active against Mycoplasma or Chlamydia: These organisms lack classical peptidoglycan cell walls and are intrinsically resistant.
    • Long-term solution storage: Aqueous solutions degrade rapidly at room temperature; only freshly prepared solutions should be used for critical assays (see product guidance).
    • Protein expression artifacts: Overuse in recombinant workflows can select for ampicillin-resistant mutants, confounding selection stringency.
    • Misinterpreting solubility: Solubility values are medium-dependent; verify compatibility with assay buffers before use.

    Workflow Integration & Parameters

    Ampicillin sodium is integrated into antibacterial activity assays by dilution into LB or defined media at desired concentrations (typically 10–100 μg/ml). For recombinant protein workflows, such as the expression and purification of annexin V in E. coli W3110, ampicillin sodium at 50 μg/ml provides effective selection pressure without interfering with downstream biochemical analyses (Burger et al., 1993). Storage at -20°C is required to maintain product integrity; it is shipped on blue ice and should not be exposed to repeated freeze-thaw cycles. Solutions are not recommended for long-term storage due to hydrolysis risk. For high-throughput or resistance modeling, see advanced assay protocols—this article expands by providing verified solubility and inhibition benchmarks.

    For comprehensive comparison with similar β-lactam antibiotics and detailed troubleshooting, the article here provides broader context, while the current resource delivers updated, quantitative parameters for Ampicillin sodium (A2510).

    Conclusion & Outlook

    Ampicillin sodium remains an essential tool for antibacterial research, resistance modeling, and recombinant protein workflows. Its well-defined mechanism of competitive transpeptidase inhibition and robust solubility profile support reproducible, high-sensitivity assays. The product, as supplied by APExBIO, is characterized by high purity and validated benchmarks, ensuring reliability across diverse experimental designs. Ongoing research into β-lactamase-resistant derivatives and combination therapies will further expand its translational utility. To source high-quality Ampicillin sodium for research, visit the A2510 product page.